Medtronic Plc

MDT · NYSE · USD

PoliticiansInstitutionalInsiders

Current holders

Politician	Disclosed
Donald Trump R · EXECUTIVE	net −$26K – $1.3M 19 disclosures · 10 bought / 9 sold · last Aug 21, 2026
Scott Franklin R · HOUSE · FL	$166K – $515K $130K – $465K today 4 filings · last Feb 15, 2023
Ro Khanna D · HOUSE · CA	−$493K – $873K −$537K – $913K today 80 filings · last May 27, 2026
Daniel S. Goldman D · HOUSE · NY	$30K – $100K $35K – $115K today 2 filings · last Mar 6, 2023
Scott H. Peters D · HOUSE · CA	−$100K – $200K −$143K – $246K today 4 filings · last Sep 2, 2015
Debbie Dingell D · HOUSE · MI	$16K – $65K $19K – $79K today 2 filings · last Dec 5, 2023
Alan S. Lowenthal D · HOUSE · CA	−$14K – $63K −$16K – $58K today 4 filings · last Jul 29, 2022
Thomas J. Rooney R · HOUSE · FL	$3K – $45K $3K – $52K today 3 filings · last Nov 2, 2016
Kathy E. Manning D · HOUSE · NC	−$61K – $93K −$75K – $100K today 8 filings · last Jul 2, 2024
Carlos Curbelo R · HOUSE · FL	−$26K – $58K −$31K – $70K today 6 filings · last Aug 28, 2018

Recent transactions

Trades from May 8, 2025 – Aug 21, 2026

Politician	Type	Filed after	Amount
Donald Trump R · EXECUTIVE	Buy	48 days Aug 21, 2026 → Oct 8, 2026	≥$500K
Donald Trump R · EXECUTIVE	Buy	60 days Jul 24, 2026 → Sep 22, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	67 days Jul 17, 2026 → Sep 22, 2026	≥$1K
Donald Trump R · EXECUTIVE	Buy	76 days Jul 8, 2026 → Sep 22, 2026	≥$15K
Donald Trump R · EXECUTIVE	Buy	76 days Jul 8, 2026 → Sep 22, 2026	≥$1K
Kevin Hern R · HOUSE · OK-1	Sell	8 days Aug 24, 2026 → Sep 1, 2026	≥$15K
Donald Trump R · EXECUTIVE	Buy	59 days Jun 24, 2026 → Aug 22, 2026	≥$50K
Donald Trump R · EXECUTIVE	Sell	60 days Jun 23, 2026 → Aug 22, 2026	≥$1K
Donald Trump R · EXECUTIVE	Buy	61 days Jun 22, 2026 → Aug 22, 2026	≥$50K
Donald Trump R · EXECUTIVE	Buy	67 days Jun 16, 2026 → Aug 22, 2026	≥$15K

Congressional trading data provided by QuiverQuant

Institutional

Investors holding

2,206

13F shares

1.10B

Total invested

$87.5B

Ownership

86.1%

New positions

174

Closed positions

277

Increased positions

1,015

Reduced positions

940

Put/Call ratio

0.97

Holder	Reported	Shares	Value	Δ Qtr
BLACKROCK, INC.	8/7/2026	114M	$8.9B	+0.74%
VANGUARD CAPITAL MANAGEMENT LLC	8/13/2026	83.8M	$6.6B	+0.58%
STATE STREET CORP	9/22/2026	63.4M	$5.0B	+2.69%
VANGUARD PORTFOLIO MANAGEMENT LLC	8/13/2026	34.1M	$2.7B	+1.82%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	8/3/2026	19.9M	$2.6B	−7.30%
GEODE CAPITAL MANAGEMENT, LLC	8/12/2026	30.2M	$2.4B	+5.07%
JPMORGAN CHASE & CO	8/12/2026	27.8M	$2.2B	−45.49%
BANK OF AMERICA CORP /DE/	8/14/2026	21.3M	$1.7B	−18.04%
MORGAN STANLEY	8/13/2026	19.4M	$1.5B	−6.14%
DEUTSCHE BANK AG\	8/7/2026	18.4M	$1.4B	−2.91%
INVESCO LTD.	8/14/2026	17.9M	$1.4B	+6.54%
FRANKLIN RESOURCES INC	8/13/2026	17.6M	$1.4B	+23.81%
NORGES BANK	8/12/2026	16.6M	$1.3B	—
ROYAL BANK OF CANADA	8/14/2026	16M	$1.3B	+13.02%
BANK OF NEW YORK MELLON CORP	8/6/2026	14.7M	$1.1B	−5.21%
FIRST EAGLE INVESTMENT MANAGEMENT, LLC	8/24/2026	13.8M	$1.1B	+37.23%
CAPITAL RESEARCH GLOBAL INVESTORS	8/12/2026	13.3M	$1.0B	−68.37%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	8/13/2026	12.9M	$1.0B	+176.70%
NORTHERN TRUST CORP	8/13/2026	11.6M	$909.6M	−3.41%
AMERIPRISE FINANCIAL INC	8/14/2026	11.6M	$904.7M	−3.46%
WCM INVESTMENT MANAGEMENT, LLC	8/13/2026	10.8M	$876.1M	−3.90%
LEGAL & GENERAL GROUP PLC	8/14/2026	9.8M	$769.2M	−4.69%
GOLDMAN SACHS GROUP INC	8/14/2026	9M	$705.0M	+60.92%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	8/14/2026	8.9M	$696.7M	+3.46%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.	8/14/2026	8.9M	$696.7M	—

Insider transactions

Insider	Type	Transacted	Price	Date
Martha Geoffrey	S-SALE	50K	$95.00	Oct 15
Marinaro Michael	S-SALE	10.4K	$96.00	Oct 15

Analyst consensus

Buy51 analysts

Bearish · 0 · Hold · 20 · Bullish · 31

Earnings history

	EPS	Estimate
Q2 2025	$1.26	$1.25	Beat
Q3 2025	$1.39	$1.36	Beat
Q4 2025	$1.62	$1.58	Beat
Q1 2026	$1.26	$1.23	Beat
Q2 2026	$1.36	$1.31	Beat
Q3 2026	$1.36	$1.34	Beat
Q4 2026	$1.55	$1.54	Beat
Q1 2027	$1.45	$1.39	Beat

Peers

Company overview

IPO dateMay 2, 1973

CEOGeoffrey Straub Martha

Employees95,000

SectorHealthcare

IndustryMedical - Devices

CountryIE

ExchangeNew York Stock Exchange

Websitewww.medtronic.com

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.